NYSE:MCK - New York Stock Exchange, Inc. - US58155Q1031 - Common Stock - Currency: USD
NYSE:MCK (5/13/2025, 3:31:57 PM)
688.57
+1.05 (+0.15%)
The current stock price of MCK is 688.57 USD. In the past month the price decreased by -0.27%. In the past year, price increased by 21.79%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
COR | CENCORA INC | 18.77 | 53.93B | ||
CAH | CARDINAL HEALTH INC | 18.57 | 35.88B | ||
HSIC | HENRY SCHEIN INC | 14.8 | 8.68B | ||
AHCO | ADAPTHEALTH CORP | 14.34 | 1.22B | ||
AHG | AKSO HEALTH GROUP | N/A | 614.18M | ||
OMI | OWENS & MINOR INC | 4.7 | 566.63M | ||
WGRX | WELLGISTICS HEALTH INC | N/A | 113.15M | ||
ATPC | AGAPE ATP CORP | N/A | 100.02M | ||
COSM | COSMOS HEALTH INC | N/A | 12.96M | ||
VRAX | VIRAX BIOLABS GROUP LTD | N/A | 4.69M |
McKesson Corp. engages in providing healthcare services. The company is headquartered in Irving, Texas and currently employs 45,000 full-time employees. The company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment includes its operations in Norway, which provides distribution and services to wholesale and retail customers.
MCKESSON CORP
6555 State Highway 161
Irving TEXAS 75039 US
CEO: Brian S. Tyler
Employees: 48000
Phone: 19724464800
The current stock price of MCK is 688.57 USD. The price increased by 0.15% in the last trading session.
The exchange symbol of MCKESSON CORP is MCK and it is listed on the New York Stock Exchange, Inc. exchange.
MCK stock is listed on the New York Stock Exchange, Inc. exchange.
22 analysts have analysed MCK and the average price target is 736.62 USD. This implies a price increase of 6.98% is expected in the next year compared to the current price of 688.57. Check the MCKESSON CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MCKESSON CORP (MCK) has a market capitalization of 86.30B USD. This makes MCK a Large Cap stock.
MCKESSON CORP (MCK) currently has 48000 employees.
MCKESSON CORP (MCK) has a support level at 687.51 and a resistance level at 698.93. Check the full technical report for a detailed analysis of MCK support and resistance levels.
The Revenue of MCKESSON CORP (MCK) is expected to grow by 8.35% in the next year. Check the estimates tab for more information on the MCK EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MCKESSON CORP (MCK) has a dividend yield of 0.41%. The yearly dividend amount is currently 2.71. Check the full fundamental report for a detailed analysis of MCK dividend history, reliability and sustainability.
MCKESSON CORP (MCK) will report earnings on 2025-08-05, after the market close.
The PE ratio for MCKESSON CORP (MCK) is 20.8. This is based on the reported non-GAAP earnings per share of 33.1 and the current share price of 688.57 USD. Check the full fundamental report for a full analysis of the valuation metrics for MCK.
The outstanding short interest for MCKESSON CORP (MCK) is 1.74% of its float. Check the ownership tab for more information on the MCK short interest.
ChartMill assigns a technical rating of 8 / 10 to MCK. When comparing the yearly performance of all stocks, MCK is one of the better performing stocks in the market, outperforming 90.71% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to MCK. MCK has only an average score on both its financial health and profitability.
Over the last trailing twelve months MCK reported a non-GAAP Earnings per Share(EPS) of 33.1. The EPS increased by 20.71% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 0.92% | ||
ROA | 4.39% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 82% to MCK. The Buy consensus is the average rating of analysts ratings from 22 analysts.
For the next year, analysts expect an EPS growth of 12.34% and a revenue growth 8.35% for MCK